Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1113 results

Sanofi posts strong 2nd-qtr earnings, beating estimates

Sanofi posts strong 2nd-qtr earnings, beating estimates

31-07-2014

French pharma major Sanofi this morning reported that group sales for the second quarter of 2014 grew…

FinancialFranceGaucherGenzymeInsulin glargineMajorMiddle EastPharmaceuticalSanofi

Bayer’s 2nd-qtr earnings hit by currency, missing expectations

Bayer’s 2nd-qtr earnings hit by currency, missing expectations

30-07-2014

Germany’s pharma and life sciences major Bayer posted a solid set of second-quarter 2014 financial…

BayerCancerConsumer HealthFinancialGermanyGermanyPharmaceuticalPulmonary hypertension

Almirall's top-performing product in first half of 2014 is part of AstraZeneca selloff

Almirall's top-performing product in first half of 2014 is part of AstraZeneca selloff

30-07-2014

Spanish drug company Almirall has announced total revenues of 433.4 million euros ($508.8 million) for…

AlmirallEkliraEuroFinancialNabiximolsPharmaceuticalSpain

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

Merck's revenue drops 1% but still beats analysts' estimates for 2nd-qtr

29-07-2014

Global revenue at pharma giant Merck & Co slipped 1% but the company has still exceeded analysts’ estimates…

FinancialFinancial accountingGardasilHepatitis CIsentressMerckMerck & CoNasonexPharma giantPharmaceuticalRemicadeUSAVytorinZetia

Earnings at Pfizer tank but still just beat expectations

Earnings at Pfizer tank but still just beat expectations

29-07-2014

Taking the brunt of generic competition to former blockbuster drugs, US pharma giant Pfizer posted a…

FinancialPfizerPharmaceuticalUSA

Recordati reports first half results with sales up 6.3%

Recordati reports first half results with sales up 6.3%

29-07-2014

Italian drugmaker Recordati saw its shares rise 2.1% to 12.30 euros after the company released first…

FinancialItalyPharmaceuticalRecordatiZanidip

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options

28-07-2014

UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Zealand and Boehringer link up to advance novel peptide medicines

Zealand and Boehringer link up to advance novel peptide medicines

28-07-2014

Denmark’s Zealand Pharma has entered into a new global exclusive licence and R&D collaboration with…

Boehringer IngelheimCardio-vascularDenmarkFinancialGermanyLicensingMetabolicsPharmaceuticalResearchZealand Pharma

Pharmaceuticals, a strategic sector for the UK government

Pharmaceuticals, a strategic sector for the UK government

28-07-2014

Britain’s pharmaceuticals sector, which includes AstraZeneca and GlaxoSmithKline, two drugmakers among…

AstraZenecaEconomy of the United KingdomFinancialGlaxoSmithKlineMarkets & MarketingPharmaceuticalResearchUK

AbbVie 2nd-qtr 2014 earnings beat forecasts

25-07-2014

US drugmaker AbbVie, which has just clinched a $55 billion deal to acquire Ireland-based Shire, reported…

AbbVieFinancialHumiraPharmaceutical

PhRMA comments on Medicare Rights Center paper

25-07-2014

“Finding viable solutions to contain Medicare costs is critically important, but imposing price controls…

FinancialHealthcarePharmaceuticalPricingUSA

Eli Lilly 2nd-qtr sales takes hit from generics; net income falls 39%

24-07-2014

US pharma major Eli Lilly reported second quarter 2014 revenues fell 17% to $4.935 billion, reflecting…

Eli LillyFinancialPharmaceutical

Currency takes toll on Roche first-half results

Currency takes toll on Roche first-half results

24-07-2014

Swiss pharma major Roche, the world’s leading oncology company, this morning posted first-half 2014…

FinancialOncologyPharmaceuticalRocheSwitzerland

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

23-07-2014

UK pharma giant GlaxoSmithKline saw its shares fall 3.9% to £45.94 shortly after the company reported…

FinancialFluticasone propionateGlaxoSmithKlinePharmaceuticalPulmonologyUK

Merck strengthens commitment to Chinese growth market

Merck strengthens commitment to Chinese growth market

23-07-2014

Germany’s Merck KGaA, a leading company for high-tech products in the pharmaceutical and chemical sectors,…

ChinaFinancialMerckMerck KGaAPharmaceuticalProductionResearch

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

22-07-2014

In the latest in an ongoing takeover attempt of Allergan by Valeant, Valeant has contacted financial…

AllerganBausch & LombCanadaFinancialPharmaceuticalRegulationUSAValeant Pharmaceuticals

Allergan reports strong 2nd-qtr figures but still plan to cut 1,500 jobs worldwide

Allergan reports strong 2nd-qtr figures but still plan to cut 1,500 jobs worldwide

21-07-2014

Botox maker Allergan has reported its second quarter operating results while also announcing that it…

AllerganAllerganBotoxFinancialPharmaceuticalUSA

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

18-07-2014

Ireland-headquartered drugmaker Shire, which has just accepted an increased $54 billion bid from the…

AbbVieFinancialIrelandPharmaceuticalShire

Partnerships in Latin America big business between 2009 and 2013

Partnerships in Latin America big business between 2009 and 2013

18-07-2014

Traditional partnerships (excluding mergers, acquisitions and early venture funding) where a Latin American…

BiotechnologyBusiness FinanceFinancialPharmaceuticalSouth America

Elder to strengthen existing brands following sale to Torrent

Elder to strengthen existing brands following sale to Torrent

18-07-2014

Indian drugmaker Elder Pharma has said it plans to strengthen its existing brands including Eldervit…

Elder PharmaceuticalsFinancialIndiaPharmaceuticalTorrent GroupTorrent Pharmaceuticals

Sobi revenues up 27% in 2nd-qtr 2014

Sobi revenues up 27% in 2nd-qtr 2014

18-07-2014

Biotech firm Swedish Orphan Biovitrum, announced total revenues of 662.5 million Swedish kronor ($97…

FinancialOrfadinPharmaceuticalSobiSwedish Orphan Biovitrum

Report: US state governments may spend $55 billion on hepatitis C drugs

Report: US state governments may spend $55 billion on hepatitis C drugs

17-07-2014

State legislatures in the USA will need to find billions in their budgets to purchase costly new hepatitis…

Anti-viralsExpress ScriptsFinancialGilead SciencesHealthcarePharmaceuticalSovaldiUSA

1 to 25 of 1113 results

Back to top